A case report of heart failure and death following covid۱۹

Background and aim: Some patients with covid۱۹ have several problems after recovery. One of which is inflammation of the layers of the heart and heart failure. The aim of this article is to explain a case with death after heart failure following covid۱۹. Case presentation: Patient, a ۴۱ years old man, having chest pain and pulse-free ventricular tachycardia and reduced ejection fraction is under care in critical care unit in June. About ۴ months ago, he was suffering from covid۱۹ and had symptoms including severe cough, shortage of breath, chest pain, weakness and lethargy that went to the doctor and found that had covid۱۹. Symptoms continued and the patient referred to different medical centers one after another. Despite the full use of drugs prescribed to treat covid۱۹ at home, these symptoms did not diminish and changes in the ECG cause new findings in the patient, therefor, this leads to visits to cardiologists and echo. In echocardiography performed for the first time after covid۱۹, decrease in heart ejection fraction was about ۳۰% and hardening of the walls (sclerosis) was recognized. According to the diagnosis of the physician, the client is a candidate for heart transplant due to progressive heart failure. No record of drug using or a specific disease was mentioned by the patient. New symptoms of heart failure are added to the previous symptoms and the patient's condition worsens. The patient and his family, do not take the doctor's advice that the disease is progressive seriously and do not follow up to treat the disease. As the disease progresses and the symptoms become more severe, the patient is a candidate for ICD implantation in May. After ICD implantation, the patient develops recurrent non-pulsed tachycardia. Despite the termination of this tachycardia, the electrolytes are disrupted by the ICD and eventually the patient dies in July.

کلیدواژه ها:

Covid ۱۹ ، Heart failure ، Death